Long-term, low-dose antiviral treatment opens doors for treating shingles in the eye. Will antiviral drug valacyclovir ...

It began with a burning pain in her right eye. At first, Elisabeth Cohen thought she’d gotten something in it. But the next ...

New research presented at the American Academy of Ophthalmology’s Cornea Subspecialty Day is part of the part of the 8-year ...

For the millions of Americans who suffer from shingles each year, the threat of vision loss has long been a looming concern.

There's a potential new treatment for people who develop shingles that spread to the eye. Doctors say about 8% of shingles ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...

The launch of the GSK ‘Understanding Shingles’ research findings aims to raise awareness and address the lack of knowledge ...

A bus with scientific pamphlets and educational programs for the elderly began touring 35 cities in nine provinces and ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye ...

One year of valacyclovir is beneficial for patients with herpes zoster ophthalmicus (HZO), according to a study pre ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...